Indications

This product has been shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei, C. septicum, C. haemolyticum, C. novyi, C. tetani, and C. perfringens Type C & D.

Although C. perfringens Type B is not a significant problem in North America, immunity is derived from a combination of the Type C (beta) and Type D (epsilon) fractions.

Diseases

• Clostridium chauvoei
• Clostridium haemolyticum
• Clostridium novyi
• Clostridium perfringens C
• Clostridium perfringens D
• Clostridium septicum
• Clostridium tetani

Dosage

CATTLE: 5 mL injection administered subcutaneously or intramuscularly followed by a second 5 mL dose given six weeks later. Revaccinate annually with 5 mL prior to periods of extreme risk or parturition.

SHEEP: 5 mL injection administered subcutaneously followed by a second 2 mL dose given six weeks later. Revaccinate annually with 2 mL prior to periods of extreme risk or parturition.

Supplied

1 x 50 mL (Cattle 10 doses, Sheep 10 primary/25 booster doses)

1 x 250 mL (Cattle 50 doses, Sheep 50 primary/125 booster doses)

Preservative

Contains Thimerosal as a preservative.

Caution

Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant cattle. Local reactions may be observed following subcutaneous administration to cattle. Anaphylactoid reactions may occur following use. 

Antidote: Epinephrine. In case of human exposure, contact a physician.

FOR ANIMAL USE ONLY.

Contact

U.S. only: Merck Animal Health livestocktechsrvc@merck-animal-health.com or call 1-800-211-3573
For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov
For additional information, please see the product label.